Medicare Enrolled
Dr. Mohsen Arani, MD
Hematology & Oncology · The Woodlands, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Arani from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Arani? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Arani
Dr. Mohsen Arani is a hematology & oncology in The Woodlands, TX, with 20 years in practice. Based on federal Medicare data, Dr. Arani performed 268,658 Medicare services across 2,180 unique beneficiaries.
Between the years covered by Open Payments, Dr. Arani received a total of $133,827 from 121 pharmaceutical and/or device companies across 2065 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Arani is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 0% volume in TX$ $133,827 industry payments
Medicare Practice Summary
Medicare Utilization ↗268,658
Medicare services
Top 0% in TX for hematology & oncology
2,180
Unique beneficiaries
$4
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~13,433 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) | 117,750 | $1 | $3 |
| Filgrastim injection (Nivestym) for white blood cells | 61,740 | $0 | $1 |
| Darbepoetin injection (Aranesp) for anemia | 30,760 | $2 | $8 |
| Anti-nausea injection (fosaprepitant) | 17,250 | $0 | $1 |
| Denosumab injection (Prolia/Xgeva) | 15,480 | $18 | $55 |
| Contrast dye for imaging (iodine-based) | 9,700 | $0 | $0 |
| Anti-nausea injection (ondansetron/Zofran) | 3,504 | $0 | $0 |
| Dexamethasone injection (steroid) | 3,400 | $0 | $0 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,670 | $1 | $7 |
| Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg | 1,128 | $92 | $475 |
| Flow cytometry, additional marker | 1,038 | $19 | $63 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 995 | $23 | $82 |
| Office visit, established patient (30-39 min) | 859 | $93 | $346 |
| Drug injection, under skin or into muscle | 565 | $11 | $38 |
| Administration of chemotherapy into vein, 1 hour or less | 555 | $103 | $375 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 334 | $50 | $179 |
| Office visit, established patient (20-29 min) | 321 | $60 | $244 |
| Administration of additional new drug or substance into vein, 1 hour or less | 211 | $51 | $183 |
| Administration of chemotherapy into vein, each additional hour | 181 | $22 | $80 |
| Infusion into a vein for hydration, each additional hour | 159 | $10 | $36 |
| Office visit, established patient, complex (40-54 min) | 142 | $135 | $483 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 108 | $109 | $295 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 105 | $1,154 | $5,587 |
| New patient office visit, complex (60-74 min) | 95 | $165 | $594 |
| Ct scan of chest with contrast | 87 | $54 | $428 |
| Infusion, normal saline solution , 1000 cc | 87 | $2 | $7 |
| Injection, diphenhydramine hcl, up to 50 mg | 76 | $1 | $3 |
| CT scan of abdomen and pelvis with contrast | 73 | $172 | $804 |
| Irrigation of implanted venous access drug delivery device | 56 | $19 | $73 |
| Hospital follow-up visit, moderate complexity | 45 | $64 | $204 |
| Flow cytometry technique for dna or cell analysis, first marker | 44 | $59 | $194 |
| Complete ultrasound scan of abdomen | 27 | $52 | $285 |
| Injection of additional new drug or substance into vein | 24 | $12 | $44 |
| Initial hospital admission, high complexity | 23 | $140 | $499 |
| Telephone medical discussion with physician, 11-20 minutes | 22 | $49 | $239 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 18 | $18 | $61 |
| CT scan of chest, without contrast | 13 | $55 | $306 |
| Telephone medical discussion with physician, 5-10 minutes | 13 | $22 | $148 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
44.4% high complexity
54.5% medium
1.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$133,827
Total received (2018-2024)
Avg $19,118/year across 7 years
Top 5% in TX for hematology & oncology
121
Companies
2,065
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$73,861 (55.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$51,440 (38.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$8,525 (6.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$30,214
2023$13,568
2022$26,904
2021$11,242
2020$15,216
2019$23,754
2018$12,929
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
OnMark, Inc.
$24,140
Foundation Medicine, Inc.
$9,195
Dova Pharmaceuticals
$7,163
Janssen Biotech, Inc.
$6,950
Coherus Biosciences Inc.
$6,608
Gilead Sciences, Inc.
$6,125
Janssen Scientific Affairs, LLC
$5,385
Mylan Institutional Inc.
$4,493
JAZZ PHARMACEUTICALS INC.
$4,224
Genentech USA, Inc.
$4,073
GENZYME CORPORATION
$3,672
US Oncology Corporate, Inc.
$3,392
GlaxoSmithKline, LLC.
$3,177
Seattle Genetics, Inc.
$2,869
AstraZeneca Pharmaceuticals LP
$2,684
Novartis Pharmaceuticals Corporation
$2,654
McKesson Specialty Care Distribution, LLC
$2,288
E.R. Squibb & Sons, L.L.C.
$2,233
Amgen Inc.
$2,082
Kite Pharma, Inc.
$1,688
Pharmacosmos Therapeutics Inc.
$1,644
PFIZER INC.
$1,529
G1 Therapeutics, Inc.
$1,516
Pharmacyclics LLC, An AbbVie Company
$1,385
BeiGene USA, Inc.
$1,318
Celgene Corporation
$1,244
Regeneron Healthcare Solutions, Inc.
$1,232
Bayer HealthCare Pharmaceuticals Inc.
$1,222
MACROGENICS, INC.
$1,104
Daiichi Sankyo Inc.
$950
Merck Sharp & Dohme Corporation
$937
Seagen Inc.
$818
Astellas Pharma US Inc
$813
Lilly USA, LLC
$796
Merck Sharp & Dohme LLC
$684
Takeda Pharmaceuticals U.S.A., Inc.
$596
Incyte Corporation
$575
Eisai Inc.
$564
Ipsen Biopharmaceuticals, Inc
$472
ABBVIE INC.
$460
Dendreon Pharmaceuticals LLC
$406
PUMA BIOTECHNOLOGY, INC.
$388
Karyopharm Therapeutics Inc.
$366
Blueprint Medicines Corporation
$360
Heron Therapeutics, Inc.
$334
Aurobindo Pharma USA, Inc.
$289
AVEO Pharmaceuticals, Inc.
$287
RECORDATI_RARE_DISEASES_INC.
$287
Alexion Pharmaceuticals, Inc.
$267
Boehringer Ingelheim Pharmaceuticals, Inc.
$258
Teva Pharmaceuticals USA, Inc.
$254
MorphoSys, US Inc.
$245
TESARO, Inc.
$206
Rigel Pharmaceuticals, Inc.
$206
SOBI, INC
$186
Celltrion USA Inc.
$172
Pharmacyclics LLC, an AbbVie Company
$168
Stemline Therapeutics Inc.
$167
Adaptive Biotechnologies Corporation
$167
Apellis Pharmaceuticals, Inc.
$162
Janssen Pharmaceuticals, Inc
$159
EISAI INC.
$153
TAIHO ONCOLOGY, INC.
$145
Mirati Therapeutics, Inc.
$141
EMD Serono, Inc.
$140
Agios Pharmaceuticals, Inc.
$140
Octapharma USA, Inc.
$132
PharmaEssentia USA Corporation
$128
Veran Medical Technologies, Inc.
$124
Boston Scientific Corporation
$120
Genmab U.S., Inc.
$115
Puma Biotechnology, Inc.
$113
Sandoz Inc.
$108
Spectrum Pharmaceuticals Inc.
$102
TerSera Therapeutics LLC
$102
AbbVie Inc.
$98
ADC Therapeutics America, Inc.
$92
Exelixis Inc.
$82
Taiho Oncology, Inc.
$79
Helsinn Therapeutics (U.S.), Inc.
$78
Servier Pharmaceuticals LLC
$77
Myovant Sciences Inc.
$75
Aveo Pharmaceuticals, Inc.
$60
Tempus AI, Inc
$58
Sirtex Medical Inc
$58
Immunocore Limited
$55
SERVIER PHARMACEUTICALS LLC
$52
Emmaus Medical, Inc.
$51
CTI BioPharma Corp.
$46
Sumitomo Pharma America, Inc.
$46
ImmunoGen, Inc.
$46
Legend Biotech USA Inc.
$44
Jazz Pharmaceuticals Inc.
$39
Arbor Pharmaceuticals, Inc.
$38
MEDIVATION FIELD SOLUTIONS LLC
$37
Array BioPharma Inc.
$36
Secura Bio, Inc.
$35
Kyowa Kirin, Inc.
$34
Pharming Healthcare, Inc.
$32
Epizyme, Inc.,
$32
ARRAY BIOPHARMA INC
$25
Lexicon Pharmaceuticals, Inc.
$24
Acceleron Pharma, Inc.
$23
Organon LLC
$23
Nestle HealthCare Nutrition Inc.
$22
Deciphera Pharmaceuticals Inc.
$22
Immunomedics, Inc.
$22
Biocon Biologics Inc
$22
Abbott Laboratories
$21
Verity Pharmaceuticals Inc.
$21
Bayer Healthcare Pharmaceuticals Inc.
$19
Fortovia Therapeutics, Inc.
$18
Otsuka America Pharmaceutical, Inc.
$17
AbbVie, Inc.
$17
Fresenius Kabi USA, LLC
$16
Covidien LP
$16
Genentech, Inc.
$15
Global Blood Therapeutics, Inc.
$15
UCB, Inc.
$13
TOLMAR Pharmaceuticals, Inc.
$12
Blue Earth Diagnostics Limited
$11
Top 3 companies account for 30.3% of total payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · ALUNBRIG · AVYCAZ · AYVAKIT · Abraxane · Adcetris · Alecensa · Aliqopa · Aranesp · Avastin · Axumin · BAVENCIO · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Balversa · Bavencio · Beleodaq · Blincyto · Braftovi · CABLIVI · CALQUENCE · CARDIOMEMS · CARVYKTI · CHANTIX · CINVANTI · COPIKTRA · COSELA · CREON · CYRAMZA · Cabometyx · Cimzia · Columvi · Creon · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIGARD · ELIQUIS · ELITEK · ELREXFIO · EMEND · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERBITUX · ERLEADA · EXKIVITY · Elahere · Empaveli · Endari · Enhertu · Epkinly · Erleada · FOTIVDA · FOUNDATIONACT · FOUNDATIONONE · FRUZAQLA · FULPHILA · Fabhalta · Farydak · Folotyn · Fulphila · GAZYVA · GILOTRIF · HYQVIA · Halaven · Horizant · Hulio · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INFLECTRA · INJECTAFER · INLYTA · INREBIC · Imbruvica · JADENU · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lunsumio · MARGENZA · MEKINIST · MONJUVI · MONOFERRIC · MYLOTARG · Monoferric · NERLYNX · NEXPLANON · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OGIVRI · OJJAARA · ONTRUZANT · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Ogivri · Onivyde · Orserdu · PADCEV · PANZYGA · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PROVENGE · Padcev · Perjeta · Phesgo · Pomalyst · Poteligeo · Prolia · QINLOCK · Quzyttir · REBLOZYL · RETEVMO · ROLVEDON · RUCONEST · RYBREVANT · RYDAPT · Reblozyl · Revlimid · Rezlidhia · Rituxan · SANDOSTATIN · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SPRYCEL · SUSTOL · SUTENT · SYLVANT · SYNAGIS · Somatuline Depot · Spin · Stimufend · Stivarga · SuperDimension · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TEVIMBRA · TIBSOVO · TRELEGY ELLIPTA · TUKYSA · Tavalisse · Tazverik · TheraSphere Y90 Glass Microspheres 10 GBq · Trelstar · Trodelvy · Truxima · ULTOMIRIS · Udenyca · Ultomiris · VEGZELMA · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · VYXEOS · Vectibix · Venclexta · Vitrakvi · Vonjo · WELIREG · XALKORI · XARELTO · XGEVA · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · Yescarta · ZARXIO · ZEJULA · ZEPZELCA · ZIEXTENZO · Zoladex · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (55%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 5% for hematology & oncology in TX.
Equivalent to $50 per 100 Medicare services performed
Geographic Context
Hematology & Oncologys within 10 mi
31
Per 100K population
4.7
County median income
$97,266
Nearest hospital
HOUSTON METHODIST THE WOODLANDS HOSPITAL
4.2 mi
4.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Arani is a mixed practice specialist, with above-average Medicare volume (top 0% in TX), and high industry engagement (consulting-driven, top 5%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Arani experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Arani performed 117,750 iron infusion (injectafer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Arani receive payments from pharmaceutical companies?
Yes. Dr. Arani received a total of $133,827 from 121 companies across 2,065 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Arani's costs compare to other hematology & oncologys in The Woodlands?
Dr. Arani's average Medicare payment per service is $4. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Arani) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncologys in The Woodlands
Browse hematology & oncologys in The Woodlands ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncologys in TX
Hematology & Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncologys in TX
Which TX hematology & oncologys receive the most from drug and device companies.
By company
OnMark, Inc. Payments to Doctors
See all physicians who received payments from OnMark, Inc..
By company
Foundation Medicine, Inc. Payments to Doctors
See all physicians who received payments from Foundation Medicine, Inc..
By company
Dova Pharmaceuticals Payments to Doctors
See all physicians who received payments from Dova Pharmaceuticals.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology